Evidence map›Paper›PMID 36440201›Full record

ArticleFrontiers in endocrinology2022

A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care.

Paul Dupenloup, Ryan Leonard Pei, Annie Chang, Michael Z Gao, Priya Prahalad, Ramesh Johari, Kevin Schulman, Ananta Addala, Dessi P Zaharieva, David M Maahs and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Role and Perspective of Certified Diabetes Care and Education Specialists in the Development of the 4T Program.Diabetes spectrum : a publication of the American Diabetes Association · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Paul DupenloupDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Ryan Leonard PeiDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Annie ChangDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Michael Z GaoDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Priya PrahaladDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA, United States.
Ramesh JohariDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Kevin SchulmanClinical Excellence Research Center, Stanford University, Stanford, CA, United States.
Ananta AddalaDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA, United States.
Dessi P ZaharievaDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA, United States.
David M MaahsDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, CA, United States.
David ScheinkerDepartment of Management Science and Engineering, Stanford University, Stanford, CA, United States.
Stanford University · US

Funding

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T StudyR18DK122422 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2020 to 2024
$3.2M
NIDDK NIH HHS R18 DK122422
6 · The paper itself

Abstract

Introduction: Population-level algorithm-enabled remote patient monitoring (RPM) based on continuous glucose monitor (CGM) data review has been shown to improve clinical outcomes in diabetes patients, especially children. However, existing reimbursement models are geared towards the direct provision of clinic care, not population health management. We developed a financial model to assist pediatric type 1 diabetes (T1D) clinics design financially sustainable RPM programs based on algorithm-enabled review of CGM data. Methods: Data were gathered from a weekly RPM program for 302 pediatric patients with T1D at Lucile Packard Children's Hospital. We created a customizable financial model to calculate the yearly marginal costs and revenues of providing diabetes education. We consider a baseline or status quo scenario and compare it to two different care delivery scenarios, in which routine appointments are supplemented with algorithm-enabled, flexible, message-based contacts delivered according to patient need. We use the model to estimate the minimum reimbursement rate needed for telemedicine contacts to maintain revenue-neutrality and not suffer an adverse impact to the bottom line. Results: The financial model estimates that in both scenarios, an average reimbursement rate of roughly $10.00 USD per telehealth interaction would be sufficient to maintain revenue-neutrality. Algorithm-enabled RPM could potentially be billed for using existing RPM CPT codes and lead to margin expansion. Conclusion: We designed a model which evaluates the financial impact of adopting algorithm-enabled RPM in a pediatric endocrinology clinic serving T1D patients. This model establishes a clear threshold reimbursement value for maintaining revenue-neutrality, as well as an estimate of potential RPM reimbursement revenue which could be billed for. It may serve as a useful financial-planning tool for a pediatric T1D clinic seeking to leverage algorithm-enabled RPM to provide flexible, more timely interventions to its patients.

Indexed as

Diabetes Mellitus, Type 1TelemedicineAlgorithmsBlood GlucoseChildHumansMonitoring, PhysiologicBlood Glucosealgorithm-enabled telemedicinecontinuous glucose monitoring (CGM)health economicshemoglobin A1c (HbA1c)pediatricspopulation healthremote patient monitoring (RPM)type 1 diabetes (T1D)

Identifiers

PMID36440201
PMCPMC9691757
OpenAlexW4308803099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.